Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2014 1
2016 2
2017 2
2018 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Budget impact analysis of medicines: updated systematic review and implications.
Faleiros DR, Álvares J, Almeida AM, de Araújo VE, Andrade EI, Godman BB, Acurcio FA, Guerra Júnior AA. Faleiros DR, et al. Among authors: godman bb. Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):257-66. doi: 10.1586/14737167.2016.1159958. Epub 2016 Mar 17. Expert Rev Pharmacoecon Outcomes Res. 2016. PMID: 26923561 Free article. Review.
Budget impact analysis of medicines: estimated values versus real-world evidence and the implications.
Faleiros DR, Alvares-Teodoro J, Nunes da Silva E, Godman BB, Gonçalves Pereira R, Gurgel Andrade EI, de Assis Acurcio FA, Guerra Júnior AA. Faleiros DR, et al. Among authors: godman bb. Expert Rev Pharmacoecon Outcomes Res. 2022 Mar;22(2):271-281. doi: 10.1080/14737167.2021.1927716. Epub 2021 May 27. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 33971778 Free article.
Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions.
Faleiros DR, Nunes da Silva E, Santos AC, Godman BB, Goncalves Pereira R, Guerra Junior AA. Faleiros DR, et al. Among authors: godman bb. Expert Rev Pharmacoecon Outcomes Res. 2022 Sep;22(6):927-939. doi: 10.1080/14737167.2022.2057950. Epub 2022 Apr 4. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 35320682 Free article.
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.
Malmström RE, Godman BB, Diogene E, Baumgärtel C, Bennie M, Bishop I, Brzezinska A, Bucsics A, Campbell S, Ferrario A, Finlayson AE, Fürst J, Garuoliene K, Gomes M, Gutiérrez-Ibarluzea I, Haycox A, Hviding K, Herholz H, Hoffmann M, Jan S, Jones J, Joppi R, Kalaba M, Kvalheim C, Laius O, Langner I, Lonsdale J, Lööv SÄ, Malinowska K, McCullagh L, Paterson K, Markovic-Pekovic V, Martin A, Piessnegger J, Selke G, Sermet C, Simoens S, Tulunay C, Tomek D, Vončina L, Vlahovic-Palcevski V, Wale J, Wilcock M, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL. Malmström RE, et al. Among authors: godman bb. Front Pharmacol. 2013 May 14;4:39. doi: 10.3389/fphar.2013.00039. eCollection 2013. Front Pharmacol. 2013. PMID: 23717279 Free PMC article.
11 results